Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Beginning Cash Balance (2016 - 2018)

Historic Beginning Cash Balance for BioRestorative Therapies (BRTX) over the last 8 years, with Q3 2018 value amounting to $6500.0.

  • BioRestorative Therapies' Beginning Cash Balance rose 10590.59% to $6500.0 in Q3 2018 from the same period last year, while for Dec 2018 it was $38500.0, marking a year-over-year decrease of 3420.49%. This contributed to the annual value of $38500.0 for FY2018, which is 3420.49% down from last year.
  • Per BioRestorative Therapies' latest filing, its Beginning Cash Balance stood at $6500.0 for Q3 2018, which was up 10590.59% from $7000.0 recorded in Q2 2018.
  • BioRestorative Therapies' 5-year Beginning Cash Balance high stood at $146030.0 for Q2 2015, and its period low was -$110060.0 during Q3 2017.
  • Moreover, its 5-year median value for Beginning Cash Balance was $25000.0 (2018), whereas its average is $43278.6.
  • Its Beginning Cash Balance has fluctuated over the past 5 years, first tumbled by 9312.59% in 2014, then soared by 87256.08% in 2015.
  • BioRestorative Therapies' Beginning Cash Balance (Quarter) stood at $20524.0 in 2014, then surged by 421.34% to $107000.0 in 2015, then rose by 8.0% to $115560.0 in 2016, then tumbled by 93.08% to $8000.0 in 2017, then decreased by 18.75% to $6500.0 in 2018.
  • Its last three reported values are $6500.0 in Q3 2018, $7000.0 for Q2 2018, and $25000.0 during Q1 2018.